http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011513390-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2009-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011513390-A |
| titleOfInvention | Novel flavonol compounds, bioactive extracts / fractions isolated from Ulmswarichiana, and compounds for the prevention and treatment of bone diseases |
| abstract | The present invention provides flavonol compounds and biologically active extracts / fractions obtained from Ulmswartiana that are useful in the management or prevention or treatment of bone diseases. The extract / fraction is a marker compound represented by general formula 2 K058: R 1 = R 2 = OH, K012: R 1 = R 2 = OH, 2, 3 double bonds, K068: R 1 = R 2 = H K100: R 1 = OH, R 2 = H, and these marker compounds K012, K058, K068, K100 are 6.7-12%, 1.7-4.5%,. It is characterized by being in the range of 6-1.2% and 1.7-4.5%. The present invention further provides a process for obtaining these extracts. According to another aspect of the invention, a pharmacological component comprising said compound is provided. Furthermore, the present invention provides a method for treating bone diseases by administration by oral administration, intravenous administration, subcutaneous administration, intraperitoneal administration, or intramuscular administration. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7190185-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2019059275-A1 |
| priorityDate | 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 582.